DV
Dividend Vision

CEROW — CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CEROW)

Total return is -96.4% over the past 2.5 years, 155.4 points behind SPY at 59.0%. Its deepest 1-year drawdown was 94.3%.

CERo Therapeutics Holdings Inc is an equity stock that trades as a single company security rather than a diversified fund. With an inception date of February 2024 and limited available distribution data, this holding does not currently report a dividend yield or regular distribution frequency. The lack of key fund metrics such as expense ratio and assets under management suggests this may be a newly listed or thinly traded security, making it better suited for investors seeking direct equity exposure to the therapeutics company rather than those primarily focused on dividend income.

CEROW key facts

Asset type
Stock
Asset class
Equity
Inception date
02/12/2024
Last close
$0.0025
Average volume
350.0
Beta
0.162
Payout ratio
0.0
Forward P/E
0.0